{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:50:15Z","timestamp":1781833815201,"version":"3.54.5"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>CircRNAs (circRNAs) are commonly dysregulated in a variety of human diseases and are involved in the development and progression of cancer. However, the role of circRNAs in hepatic fibrosis (HF) is still unclear. Our previous high throughput screen revealed changes in many circRNAs in mice with carbon tetrachloride (CCl4)-induced HF. For example, circCREBBP was significantly down-regulated in primary hepatic stellate cells (HSCs) and liver tissue of HF mice induced by CCl4 compared to those in the vehicle group. Overexpression of circCREBBP with AAV8-circCREBBP <jats:italic>in vivo<\/jats:italic> prevented CCl4-induced HF worsening by reducing serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) contents, liver hydroxyproline levels, collagen deposition, and levels of pro-fibrosis genes and pro-inflammatory cytokines. Furthermore, <jats:italic>in vitro<\/jats:italic> function loss and function gain analysis showed that circCREBBP inhibited HSCs activation and proliferation. Mechanically, circCREBBP acts as a sponge for hsa-miR-1291 and subsequently promotes LEFTY2 expression. In conclusion, our current results reveal a novel mechanism by which circCREBBP alleviates liver fibrosis by targeting the hsa-miR-1291\/LEFTY2 axis, and also suggest that circCREBBP may be a potential biomarker for heart failure.<\/jats:p>","DOI":"10.3389\/fphar.2021.741151","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T10:12:57Z","timestamp":1638267177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Circular RNA CREBBP Suppresses Hepatic Fibrosis Via Targeting the hsa-miR-1291\/LEFTY2 Axis"],"prefix":"10.3389","volume":"12","author":[{"given":"Ya-Ru","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Tian","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong-Wen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of Liver Fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.7150\/thno.42423","article-title":"Circular RNA circFBXW4 Suppresses Hepatic Fibrosis via Targeting the miR-18b-3p\/FBXW7 axis","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/liv.12731","article-title":"Mechanisms of Fibrosis in Acute Liver Failure","volume":"35","author":"He","year":"2015","journal-title":"Liver Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fonc.2019.00392","article-title":"CircRNA-100338 Is Associated with mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma","volume":"9","author":"Huang","year":"2019","journal-title":"Front. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/2159-8290.CD-18-0385","article-title":"Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition","volume":"8","author":"Jia","year":"2018","journal-title":"Cancer Discov."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1777","DOI":"10.1038\/cddis.2015.147","article-title":"Brain Death and Marginal Grafts in Liver Transplantation","volume":"6","author":"Jim\u00e9nez-Castro","year":"2015","journal-title":"Cell Death Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e12648","DOI":"10.1111\/cpr.12648","article-title":"Circ-SERPINE2 Promotes the Development of Gastric Carcinoma by Sponging miR-375 and Modulating YWHAZ","volume":"52","author":"Liu","year":"2019","journal-title":"Cell Prolif."},{"key":"B8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ajmg.a.38626","article-title":"Further Delineation of an Entity Caused by CREBBP and EP300 Mutations but Not Resembling Rubinstein-Taybi Syndrome","volume":"176","author":"Menke","year":"2018","journal-title":"Am. J. Med. Genet. A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","article-title":"Translation of CircRNAs","volume":"66","author":"Pamudurti","year":"2017","journal-title":"Mol. Cel."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.2147\/IJN.S145951","article-title":"Nanoparticles for the Treatment of Liver Fibrosis","volume":"12","author":"Poilil Surendran","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41419-020-2230-9","article-title":"circRNA-002178 Act as a ceRNA to Promote PDL1\/PD1 Expression in Lung Adenocarcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"Cel Death Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s00535-019-01585-7","article-title":"Integrated Analysis of circRNAs and mRNAs Expression Profile Revealed the Involvement of Hsa_circ_0007919 in the Pathogenesis of Ulcerative Colitis","volume":"54","author":"Wang","year":"2019","journal-title":"J. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fimmu.2019.00639","article-title":"Roles of CircRNAs in Autoimmune Diseases","volume":"10","author":"Xia","year":"2019","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2020.07.012","article-title":"LEFTY2 Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Regulating the TGF-\u03b21\/Smad3 Pathway","volume":"126","author":"Yang","year":"2020","journal-title":"Mol. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/15548627.2017.1312041","article-title":"The Emergence of Noncoding RNAs as Heracles in Autophagy","volume":"13","author":"Zhang","year":"2017","journal-title":"Autophagy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","article-title":"siRNA- and miRNA-Based Therapeutics for Liver Fibrosis","volume":"214","author":"Zhao","year":"2019","journal-title":"Transl Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1038\/ncomms11215","article-title":"Circular RNA Profiling Reveals an Abundant circHIPK3 that Regulates Cell Growth by Sponging Multiple miRNAs","volume":"7","author":"Zheng","year":"2016","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.gene.2018.08.052","article-title":"Preliminary Screening and Functional Analysis of Circular RNAs Associated with Hepatic Stellate Cell Activation","volume":"677","author":"Zhou","year":"2018","journal-title":"Gene"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1159\/000495556","article-title":"Thymosin-\u03b24 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835\/miR-155\/FoxO3 Signaling Pathway","volume":"51","author":"Zhu","year":"2018","journal-title":"Cell Physiol. Biochem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.741151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T10:12:58Z","timestamp":1638267178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.741151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":19,"alternative-id":["10.3389\/fphar.2021.741151"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.741151","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"article-number":"741151"}}